Clinical Trial: Study to Assess the Safety and Effectiveness of Beltaven(R) in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309822) titled 'Study to Assess the Safety and Effectiveness of Beltaven(R) in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.' on Dec. 16.

Brief Summary: Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltaven(R) With Apis mellifera, Polistes dominula or Vespula spp. allergic patients

Study Start Date: Feb. 01

Study Type: OBSERVATIONAL

Condition: Allergy

Recruitment Status: RECRUITING

Sponsor: Probelte Pharma S.L.U.

Published by HT Digital Content Services with permission from Health Daily Digest....